Should not be pre- ,;crl bed without thorou gh knat1ledg, of dose, indications and to:xicity as contained in accompan ying literature . CYTOTOXIC AGENT IFO!I SING'LI DOSE USE SURIU, IION-P'IJIOG flll.C IFO!I PAIIEIIJiE !RAL U6E 460- 630-01 C E'.61 ND C 1 0019-955-01 Cyclophosphamide for Injection, USP 500mg MUST B E DILUT ED FOR IV INFUSION &only OR DIRECT INJECTION USE 1 Single Dose Vial Baxter Manufactured by Bart.er He-alt~care Corporation Deeli ield, IL 60015 USA l O T/EJ<P 2636 B507 1 111111111 I II ' ' I Cyclophosphamide for Injection, USP 500 mg ~ only MUST BE DILUT E D FOR IV INFUSION OR DIRECT INJECTION USE 1 Single Dose Vial Ii 3 II 5501 page 9 of 9Baxter Manufactured byBaxter Healthcare CorporationDeerfield, IL 60015 USAProtocol ADU-CL-02-v8Aduro Biotech, Inc. CRS-207 with Pemetrexed and Cisplatin Version 8, 08 March 2018 Page 131